Skip to main content

Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

  • Recalled Aprepitant Capsules 125 mg – NDC 0781-2323-68 – Carton
  • Recalled Aprepitant Capsules 125 mg – NDC 0781-2323-06 – Blister
  • Recalled Lidocaine and Prilocaine Cream - 5 gram tube - NDC 0168-0357-05
  • Recalled Lidocaine and Prilocaine Cream - Carton of 5 – 5 gram tubes - NDC 0168-0357-55
  • Recalled Lidocaine and Prilocaine Cream - Carton of 5 – 5 gram tubes with 12 dressings - NDC 0168-0357-56
Name of Product:
Aprepitant capsules and Lidocaine and Prilocaine cream

The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

New Instructions
Recall Date:
March 09, 2023

About 156,750

Consumer Contact

Sandoz toll-free at 866-300-2207 from 8 a.m. to 5 p.m. ET Monday through Friday, email at or online at or and click on “Product Safety Notices” below the carousel for more information.

Recall Details


This recall involves prescription drugs Aprepitant 125 mg capsules sold in cartons containing one blister card of 6 capsules and 5 gram tubes of Lidocaine and Prilocaine cream sold in cartons containing 5 tubes and packed with or without 12 dressings. The Aprepitant capsules are in a non-child resistant blister card packaged in a carton that has the name “Sandoz,” the name of the medication, dosage, NDC number, lot number, and expiration date on the carton and on the blister cards. The warnings “This unit-dose packaging is not child-resistant” and “For institutional use only” are listed on the carton.

The Lidocaine and Prilocaine cream is packaged in a 5 gram tube with a continuous thread white closure. The name “fougera®,” the name of the medication, dosage and NDC number are printed on the carton and tube and the expiration date and lot number are printed on the carton and stamped on the crimp of the tube. The warning “FOR HOSPITAL USE ONLY” is printed on the carton and the tube.

The recall includes the following:

Product Description

NDC Number

Lot Number


Expiration Date

Aprepitant Capsules 125 mg


0781-2323-68 Carton of 1 Blister Pack of 6 capsules

0781-2323-06 Blister Pack







Lidocaine and Prilocaine 2.5%/2.5% Cream 5 gram Tubes


0168-0357-56 Carton of 5 tubes and 12 dressings

0168-0357-55 Carton of 5 tubes

0168-0357-05 Tube






















Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.


None reported

Sold At:
Pharmacies nationwide as a prescribed medicine from October 2020 through January 2023. The prices of the medications varied based on health insurance terms and other factors.
Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)

Sandoz Inc., of Princeton, New Jersey (Aprepitant Capsules)

Manufactured In:
Slovenia (Aprepitant Capsules) and United States (Lidocaine and Prilocaine cream)
Recall number:

Note: Individual Commissioners may have statements related to this topic. Please visit to search for statements related to this or other topics.

If you are experiencing issues with a recall remedy or believe a company is being non-responsive to your remedy request, please use this form and explain the situation to CPSC.
About the U.S. CPSC

The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.

Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.

For lifesaving information:
Choose Your Recall Emails Get Notified About Each Recall via Email.
Report an unsafe product